Puma Biotechnology, Inc
Price
FilingsNewest: 10-Q, Quarterly reportAug 6 →InsidersNo open-market buys. 9 insiders sold $991,800, 11 of 12 sales on a 10b5-1 plan.→HoldersAcorn Capital 8.1%BlackRock 7.4%American Century Companies 4.5%→PeersClosest companies: MREO, ORIC, BCYC→
From the filings
Figures
- Revenue
- $231.2Mlast 12 months
- Net income
- $26.7Mlast 12 months
- Operating cash flow
- $53.6Mlast 12 months
- Cash and equivalents
- $36.5Mat the last balance sheet
- Total debt
- $0.00at the last balance sheet
- Shares outstanding
- 51.1M shareson issue